oral compositions useful for controlling dental plaque and gingivitis and for preventing caries are produced comprising a cationic antimicrobial agent and an anti-stain agent which reduces the staining effect of the cationic antimicrobial.
|
1. An oral composition useful for controlling dental plaque and gingivitis and for preventing caries which comprises from 0.1% to about 1.0% w/w or w/v of a cationic antimicrobial agent otherwise tending to stain teeth, and useful for controlling dental plaque and gingivitis and for preventing caries selected from the group consisting of a bisbiguanide or quaternary ammonium compound and from 0.01% to 10.0% w/w or w/v of malic acid effective to inhibit said teeth staining, in combination with a pharmaceutically acceptable carrier.
2. A composition according to
3. A composition according to
composition is from about 5.0 to about 8∅ 4. A composition according to
5. A composition according to
6. A composition according to
7. A composition according to
8. A composition according to
9. A composition according to
10. A composition according to
11. A composition according to
12. A composition according to
13. A composition according to
14. A composition according to
15. A composition according to
16. A composition according to
17. A composition according to
18. A composition according to
19. A composition according to
20. A composition according to
composition between 5.0 and 8.0 and purified water UPS, q.s. 21. In the art of inhibiting teeth staining caused by a cationic anti-microbial agent which is useful for controlling dental plaque and gingivitis and for preventing caries selected from the group consisting of a bisbiguanide or a quaternary ammonium compound, said cationic anti-microbial agent being utilized in an amount of from 0.01% to about 1.0% w/w or w/v, the improvement which consists essentially of the step of orally utilizing together with said cationic anti-microbial agent, an amount of malic acid effective to inhibit teeth staining caused by the otherwise useful cationic anti-microbial agent, said amount of malic acid being from 0.01% to 10.0% w/w or w/v. 22. The improvement according to claim 21 wherein the amount of malic acid is from 0.1% to 1.0% w/w or w/v. 23. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in mouthwash form. 24. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in oral rinse form. 25. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in dentifrice form. 26. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in toothpowder form. 27. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in oral solution form. 28. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in gel form. 29. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in a form suitable for dispensing through a water jet. 30. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in a breath freshener form. 31. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in an aerosol form. 32. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in a gargle form. 33. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in the form of a troche. 34. The improvement according to claim 21 wherein the cationic anti-microbial agent and the malic acid are utilized in the form of a lozenge. |
|||||||||||||||||
The present invention is concerned with oral compositions useful for controlling dental plaque and gingivitis and for preventing caries. The active agent is a cationic antimicrobial agent, such as bisbiguanides or quaternary ammonium compounds, which agents are known in the art to be useful for such purposes. It is also known in the art that cationic antimicrobial agents such as bisbiguanides and quaternary ammonium compounds have the disadvantages of staining teeth. The present invention provides an oral composition utilizing bisbiguanides or quaternary ammonium compounds together with an anti-stain agent which reduces the staining effect of the bisbiguanide or quaternary ammonium compound to a level which is cosmetically acceptable.
It is known in the art that bisbiguanides inhibit the formation of plaque and caries (see U.S. Pat. No. 1,365,030) and that anti-calculus agents may be combined therewith to inhibit the tendency of the bisbiguanides to stain the oral surfaces (see U.S. Pat. No. 3,934,002). Among the anti-calculus agents disclosed in U.S.Pat. No. 3,934,002 are quaternary ammonium compounds, zinc phenolsulfonate, hydroxyquinoline, citric acid, lactic acid and pharmaceutically acceptable salts thereof.
The present invention is based on the surprising discovery that malic acid markedly inhibits the staining on oral surfaces of the bisbiguanide or quaternary ammonium active agent of the instant compositions.
More particularly, the present invention comprises an oral composition useful for controlling dental plaque and gingivitis and for preventing caries which comprises an effective amount of a bisbiguanide or quaternary ammonium compound which is capable of controlling dental plaque and gingivitis and preventing caries and a stain-inhibiting amount of malic acid.
According to one embodiment of the present invention the antimicrobial agent is a bisbiguanide.
According to another embodiment of the present invention the antimicrobial agent is a quaternary ammonium compound.
According to another embodiment of the present invention the amount of antimicrobial agent is from 0.01% to about 1.0% w/w based on the total weight of ingredients or w/v when in liquid form.
According to another embodiment of the present invention the amount of malic acid is from 0.1% to 10.0% w/w or w/v, especially from 0.1% to 1.0%.
According to another embodiment of the present invention the pH of the composition is from about 5.0 to about 8∅
According to another embodiment of the present invention the bisbiguanide is 1,6-bis(2-ethylhexyldiguanido hexane)dihydrochloride [alexidine dihydrochloride]; 1,6-bis(2-ethylhexyl diguanido hexane)dihydrofluoride; 1,6-bis(2-ethylhexyl diguanido octane)dihydrochloride; 1,6-bis(2-ethylhexyl diguanido nonane)dihydrochloride; 1,6-bis(2-ethylhexyl diguanido dodecane)dihydrochloride; or 1,6-di(4-chlorophenyl diguanido hexane)dihydrochloride or the diacetate or digluconate salt thereof. Alexidine dihydrochloride is especially preferred.
According to another embodiment of the present invention the quaternary ammonium compound is dodecyl dimethyl(2-phenoxyethyl)-ammonium; benzyldimethyl(2-)2-(p-1,3,3-tetramethyl butyl phenoxy)ethoxyl)ethyl)ammonium; p-bromobenzyldimethyl-γ-(2'-isopropyl, 4'-chloro, 5'-methyl phenoxy)propyl ammonium; 1-hexadecyl-pyridinium salt; acylchloaminoformylmethyl pyridinium chloride-iodide complex; 1-alkyl-4-aminoquinaldinium salt; decamethylene bis(4-aminoquinaldinum chloride or hexadecamethylene bis(isoquinolinium chloride).
The usual flavoring agents, binders, sudsing agents, humectants, alcohols, fragrances, abrasives and excipients known in the art can be added to the compositions of the present invention.
When the oral composition of the present invention is in the form of a mouthwash, oral rinse or gargle, the composition is brought into contact with the oral cavity and then expectorated. A dose of 15 to 20 ml. for adults and about 10 ml. for children is generally sufficient when used on a daily basis.
When the instant composition is in the form of a dentifrice, such as a paste, powder, concentrate, solution or gel for direct application to the teeth, it can be used in the normal manner in which a toothpaste is used. When the oral composition of the present invention is in a concentrate for use with mechanical irrigation devices such as a water jet or "water pik" type device, approximately 10 to 15 ml. should be sprayed into the mouth and circulated in the oral cavity and then be expectorated. When the present composition is in the form of a breath freshener, either pump spray or aerosol type, approximately 10 to 15 ml. should be sprayed into the mouth, circulated therethrough and expectorated. When the composition of the present invention is in the form of a troche or a lozenge, it should be allowed to dissolve in the mouth and then be expectorated.
The following nonlimitative example more particularly illustrates the present invention.
| ______________________________________ |
| Ingredients Percent W/V |
| ______________________________________ |
| Alexidine Dihydrochloride |
| 0.035 |
| Alcohol USP 15.0 |
| Glycerin USP 10.0 |
| Flavor 0.4 |
| Sodium Saccharin 0.02 |
| Malic Acid 0.382 |
| Buffering Agent to pH 5.0-8.0 |
| Water USP q.s. |
| ______________________________________ |
The mouth-rinse is used in 15 ml. doses for adults to rinse the mouth and then is expectorated. For children in the 6 to 12 year old range, 10 ml. is the recommended mouth-rinsing dose.
| Patent | Priority | Assignee | Title |
| 4886658, | Dec 14 1988 | Procter & Gamble Company, The | Oral treatment method for reducing plaque with reduced staining |
| Patent | Priority | Assignee | Title |
| 1275275, | |||
| 3124506, | |||
| 3151028, | |||
| 3887701, | |||
| 3925543, | |||
| 3934002, | Jun 30 1972 | The Procter & Gamble Company | Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies |
| 3937805, | Nov 10 1971 | Colgate-Palmolive Company | Method of making dentifrice compositions containing insolubilized salts of 1,6-di-(p-chlorophenyl biguanido) hexane |
| 3937807, | Mar 06 1973 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| 4001393, | Jan 20 1973 | Blendax-Werke R. Schneider GmbH & Co. | Means for caries prophylaxis |
| 4051234, | Aug 09 1974 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
| 4067962, | Aug 01 1975 | The Procter & Gamble Company | Oral compositions containing trifluoromethyl phenyl bis-biguanides as antiplaque agents |
| 4183916, | Mar 31 1978 | BEECHAM INC A CORP OF | Oral compositions |
| GB1365030, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Nov 09 1981 | Beecham Inc. | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Date | Maintenance Schedule |
| Sep 27 1986 | 4 years fee payment window open |
| Mar 27 1987 | 6 months grace period start (w surcharge) |
| Sep 27 1987 | patent expiry (for year 4) |
| Sep 27 1989 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Sep 27 1990 | 8 years fee payment window open |
| Mar 27 1991 | 6 months grace period start (w surcharge) |
| Sep 27 1991 | patent expiry (for year 8) |
| Sep 27 1993 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Sep 27 1994 | 12 years fee payment window open |
| Mar 27 1995 | 6 months grace period start (w surcharge) |
| Sep 27 1995 | patent expiry (for year 12) |
| Sep 27 1997 | 2 years to revive unintentionally abandoned end. (for year 12) |